Nitrilotriacetic acid (NTA): Target Organs and Levels of Evidence for TR-006
Bioassays of Nitrilotriacetic Acid (NTA) and Nitrilotriacetic Acid, Trisodium Salt, Monohydrate (Na3-NTA-H2O) for Possible Carcinogenicity (CASRN 139-13-9) (NTA) (CASRN 18662-53-8) (Na3-NTA-H2O)
Chemical (Study Title) CASRN |
Peer Review Date | Route/Exposure Levels | Study Laboratory |
---|---|---|---|
Nitrilotriacetic acid (NTA) 139-13-9 |
03/25/1977 | Dosed-Feed R: 0,7500,15000, M: 0,2500,5000,7500,15000 PPM/50 PER GROUP |
Litton Bionetics, Inc. |
Levels of Evidence
Male Rats: Positive
Type | Organ/Tissue (Lesion) |
---|---|
Neoplastic Lesions |
|
Female Rats: Positive
Type | Organ/Tissue (Lesion) |
---|---|
Neoplastic Lesions |
|
Male Mice: Positive
Type | Organ/Tissue (Lesion) |
---|---|
Neoplastic Lesions |
|
Female Mice: Positive
Type | Organ/Tissue (Lesion) |
---|---|
Neoplastic Lesions |
|
Chemical (Study Title) CASRN |
Peer Review Date | Route/Exposure Levels | Study Laboratory |
---|---|---|---|
Nitrilotriacetic acid trisodium monohydrate 18662-53-8 |
03/25/1977 | Dosed-Feed 0,200,2000,20000 PPM/48 PER GROUP |
SRI International |
Levels of Evidence
Male Rats: Positive
Type | Organ/Tissue (Lesion) |
---|---|
Neoplastic Lesions |
|
Female Rats: Positive
Type | Organ/Tissue (Lesion) |
---|---|
Neoplastic Lesions |
|
Chemical (Study Title) CASRN |
Peer Review Date | Route/Exposure Levels | Study Laboratory |
---|---|---|---|
Nitrilotriacetic acid trisodium monohydrate 18662-53-8 |
03/25/1977 | Dosed-Feed R: 0,7500,15000, M: 0,2500,5000 PPM/50 PER GROUP |
Litton Bionetics, Inc. |
Levels of Evidence
Male Rats: Equivocal
Type | Organ/Tissue (Lesion) |
---|---|
Neoplastic Lesions |
|
Female Rats: Equivocal
Type | Organ/Tissue (Lesion) |
---|---|
Neoplastic Lesions |
|